BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics
The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a pre-solicitation notice for a potential future project opportunity: TACTIC, or Threat-Agnostic CBRN Therapeutics. The anticipated effort would support development of therapeutics that address host dysregulation caused by chemical, biological, radiological, and nuclear, or CBRN, threats. BARDA is […]
BARDA Previews TACTIC Program for Threat-Agnostic CBRN Therapeutics Read More »